Related Experiment Video

Updated: Jul 16, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: an association and meta-analysis

Behrooz Z Alizadeh1, Peter Eerligh, Arno R van der Slik

  • 1Complex Genetic Section, Department of Medical Genetics, University Medical Center Utrecht, P.O. Box 85060, 3508 AB Utrecht, The Netherlands.

Molecular Immunology
|March 14, 2007
PubMed

Insights

Genetic variations in the MHC Class I chain-related A (MICA) gene show complex associations with Type 1 Diabetes (T1D). While some MICA variants influence T1D risk, particularly with specific HLA haplotypes, no independent MICA association with T1D was found.

Area of Science:

  • Immunogenetics
  • Human Genetics
  • Molecular Biology

Background:

  • The human leukocyte antigen (HLA) complex on chromosome 6 is strongly linked to Type 1 Diabetes (T1D), but does not fully explain the genetic basis.
  • The MHC Class I chain-related A (MICA) gene, located within the HLA region, has been investigated as a potential contributor to T1D susceptibility, with conflicting previous reports.

Purpose of the Study:

  • To investigate the association of MICA gene variations with T1D in a cohort of juvenile-onset T1D patients and controls.
  • To conduct a meta-analysis of existing studies to confirm MICA-T1D associations.
  • To examine potential HLA-independent associations of MICA with T1D.

Main Methods:

  • A case-control study involving 350 individuals with juvenile-onset T1D and 540 controls.
  • Meta-analysis combining data from 14 independent studies.
  • Conditional analysis of MICA alleles in conjunction with known T1D-associated HLA class II haplotypes (DQ2DR17 and DQ8DR4).

Main Results:

  • The MICA*A5 variant was initially associated with increased T1D risk in the case-control study, while MICA*A6 showed decreased risk.
  • Meta-analysis did not confirm the association for MICA*A5 with T1D.
  • MICA*A6 showed increased T1D risk with HLA DQ2DR17 but decreased risk with HLA DQ8DR4.
  • MICA*A9 was associated with increased T1D risk on DQ8DR4 haplotypes.

Conclusions:

  • MICA gene variations do not appear to have an independent association with Type 1 Diabetes.
  • The observed associations of MICA alleles with T1D risk are dependent on specific HLA class II haplotypes.
  • The co-inheritance of MICA*A6 with the HLA DQ2DR17 haplotype suggests this haplotype may harbor additional T1D genetic factors.

More Related Videos

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...